Alkem Laboratories Ltd. (ALKEM): Alkem Laboratories Share Price rises 2.12% to Rs 5,298.95
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Alkem Laboratories Share Price rose 2.12% to Rs 5,298.95 today, adding Rs 110 from the previous close of Rs 5,188.95. The company’s market capitalisation stood at Rs 61,635.76 Cr, placing today’s move in a clear market-value context. The stock opened at Rs 5,156.65, touched the same level as the day’s low, and closed at the day’s high of Rs 5,298.95. Univest tracks this Alkem Laboratories Share Price move as part of its live stock news coverage, but the supplied data does not establish a company-specific catalyst for the rise.
For readers following Alkem Laboratories Share Price Today, the important point is that the price event is verified by the day’s numbers, not by a stated reason. In Univest research terms, this is a factual share price rise that deserves attention because it combines a positive close, a higher market cap and a valuation profile that can be compared against the healthcare and pharmaceuticals peer set. The article below covers Alkem Laboratories Stock News, valuation, sector context and peer positioning without adding any unsupported cause.
Alkem Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,298.95 |
| Previous Close | Rs 5,188.95 |
| Today's Move | Rs 110 (+2.12%) |
| Open | Rs 5,156.65 |
| High | Rs 5,298.95 |
| Low | Rs 5,156.65 |
| Turnover | Rs 1.45 crore |
| Market Capitalisation | Rs 61,635.76 crore |
| Market Cap Category | Large Cap |
Alkem Laboratories Ltd. (ALKEM) rose to Rs 5,298.95 from the previous close of Rs 5,188.95, a move of Rs 110 or 2.12%. The stock opened at Rs 5,156.65, reached a high of Rs 5,298.95, recorded a low of Rs 5,156.65.
Alkem Laboratories Share Price Today moved from Rs 5,188.95 at the previous close to Rs 5,298.95, a gain of Rs 110 or 2.12%. The stock opened at Rs 5,156.65, traded between Rs 5,156.65 and Rs 5,298.95, and finished at the day’s high. Turnover for the session was Rs 1.45 Cr. The supplied data confirms the day’s price rise and the end-of-session strength in the close, but it does not establish a company-specific catalyst for the move. For Alkem Laboratories Stock News readers, the key factual takeaway is the direction of the price, the size of the gain and the fact that the day’s high and close matched at Rs 5,298.95.
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 61,635.76 crore |
| P/E Ratio | 28.76x |
| P/B Ratio | 4.34x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.02% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 28.76x, P/B 4.34x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.
Alkem Laboratories Ltd. has a market capitalisation of Rs 61635.76 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.76x, P/B at 4.34x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 180.45, book value per share of Rs 1196.51, dividend yield of 1.02%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 28.76x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 47.81x |
| Benchmark P/E Range | 3.45x to 661.74x |
| Company P/B Ratio | 4.34x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 61,635.76 crore |
| Benchmark Median Market Cap | Rs 735.67 crore |
Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 28.76x, which is below the benchmark median of 31.35x, a difference of -8.26%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.78%, a difference of +55.26%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.65%, a difference of +55.9%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,277.97 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,965.63 | 83.5 | 13.83 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.11 | 20.44 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 28.76x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 61,635.76 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price rose 2.12% today and closed at Rs 5,298.95.
- The stock added Rs 110 versus the previous close of Rs 5,188.95.
- Market capitalisation stood at Rs 61,635.76 Cr, which gives scale to the move.
- P/E of 28.76 is below the industry median of 31.35 in the same-industry benchmark.
- ROE of 18.29% and ROCE of 21.28% both stand above benchmark medians.
About Alkem Laboratories
Alkem Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s supplied data in this note is financial and market-focused rather than segment-heavy, so the visible description stays close to what is verified. Alkem Laboratories Share Price is tracked as a listed pharmaceutical company on NSE and BSE, and its market capitalisation of Rs 61,635.76 Cr places it among the larger names in the industry dataset. The company’s financial profile in the supplied information includes EPS of Rs 180.45, book value of Rs 1,196.51 and dividend yield of 1.02%, which provide context for how the market may be valuing the business. Univest uses this kind of company overview to connect stock moves with the underlying business profile rather than with unsupported headlines.
For readers studying Alkem Laboratories Fundamental Analysis, the key point is that the company combines a sizeable market presence with positive profitability metrics. That makes Alkem Laboratories Stock Price useful to follow not only as a daily mover, but also as part of a wider view of healthcare sector valuations, company financials and stock performance across the Indian Stock Market.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest lets users track Alkem Laboratories Share Price Live, Alkem Laboratories Share Price Today, valuation ratios, company financials, shareholding pattern, 52-week levels and market insights in one place. Readers can also follow Alkem Laboratories Stock News, Alkem Laboratories Share Price Update and broader sector context as new data arrives. For anyone monitoring Alkem Laboratories Stock Gaining Today, Univest keeps the factual stock profile organised for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Alkem Laboratories Share Price rise today?
Ans. The supplied data confirms that Alkem Laboratories Share Price rose 2.12% to Rs 5,298.95, but it does not establish a company-specific catalyst. The event is verified by price and close data, not by a stated reason.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price today is Rs 5,298.95. It was up Rs 110, or 2.12%, from the previous close of Rs 5,188.95, and the stock ended at the day’s high.
What is Alkem Laboratories market capitalisation?
Ans. Alkem Laboratories market capitalisation is Rs 61,635.76 Cr. In the same-industry benchmark, that is well above the median market cap of Rs 735.67 Cr and the average of Rs 13,941.93 Cr.
How does Alkem Laboratories look on valuation?
Ans. Alkem Laboratories has a P/E of 28.76 and a P/B of 4.34. The P/E is below the industry median of 31.35, while the P/B is close to the benchmark average of 4.25.
What do Alkem Laboratories ROE and ROCE show?
Ans. ROE is 18.29% and ROCE is 21.28% for Alkem Laboratories. Both measures are above the industry medians of 11.78% and 13.65%, respectively, which adds context to the stock’s profile. ROE stands at 18.29%.
How do Alkem Laboratories EPS, book value and dividend yield read?
Ans. Alkem Laboratories reports EPS of Rs 180.45, book value of Rs 1,196.51 and dividend yield of 1.02%. These figures help explain the company’s earnings, accounting net worth and payout context.
How does Alkem Laboratories compare with peers?
Ans. In the supplied peer set, Alkem Laboratories has a smaller market cap than Sun Pharma, Divi’s and Torrent, but stronger profitability than some peers on ROE and ROCE. Its valuation also remains below several higher-multiple names.
Can investors track Alkem Laboratories Share Price on Univest?
Ans. Yes. Univest tracks Alkem Laboratories Share Price Live, Alkem Laboratories Stock News, valuation ratios, company financials, shareholding pattern and 52-week levels, making it easier to review the stock in one place.
